BioWorld: The Daily Biopharmaceutical and Medical Technology …
WEBRadiopharmaceutical company Telix Pharmaceuticals Ltd. is continuing its buying spree to shore up dominance in the radiopharmaceutical market with its latest acquisition of... More in BioWorld Asia. Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries.
Roche launches breakthrough 12-target PCR test | BioWorld
WEB1 day ago · Roche AG’s new test using its temperature-activated generation of signal technology is the next step in PCR evolution, Igor Kozlov, head of Reagent Research and Design at Roche Diagnostics Solutions, told BioWorld. The Cobas Respiratory flex test can detect up to 12 of the most common respiratory viruses using a single PCR test.
BioWorld: The Daily Biopharmaceutical News Source
WEBThe FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating schizophrenia. The fixed dose combination of xanomeline-trospium is the first to act via a novel mechanism for the serious psychiatric disorder in over 50 years, finally expanding the treatment options beyond dopamine-targeted therapies.
BioWorld Science: The Daily Drug R&D News Source
WEBEnjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription. Daily news focused on drug discovery, delivery and preclinical research. Coverage includes: Congress highlights, key studies from peer-reviewed journals, chemical structure images, pharmacology ...
Today's news in brief | BioWorld
WEBSep 27, 2024 · BioWorld briefs for September 27, 2024. Nine years on from securing $3.84 million for a phase I clinical trial to test the formulation, with results showing it overcame side effects that had confounded... Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like Medtronic plc ...
China - BioWorld
WEBSep 24, 2024 · China biotechs rise to challenge Ozempic, Wegovy. Sep. 17, 2024. By Marian (YoonJee) Chu. No Comments. Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster therapies in China.
Welcome to the new BioWorld Science
WEBSep 12, 2022 · BioWorld Science has now been migrated onto the same platform as the full suite of BioWorld news services, providing an improved experience and expanded news offering. The new site features many enhancements, which you can read about here.Frequently Asked Questions are answered here. In addition to BioWorld Science content, you can now read headlines and summaries from the flagship news ...
In the clinic | BioWorld
WEBSep 18, 2024 · In the clinic for September 16, 2024. Clinical updates, including trial initiations, enrollment status and data readouts and publications: Exact Sciences, Icecure, Merit Medical, Natera. Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors.
Clinical - BioWorld
WEBSep 26, 2024 · The risk and benefit of Pfizer Inc.’s oral sickle cell disease drug Oxbryta (voxelotor) has flipped, prompted by what the company called new clinical data indicating “an imbalance in vaso-occlusive crises and fatal events” that need more study. Based on an EMA recommendation, Pfizer said it is voluntarily recalling all lots of Oxbryta ...
Coronavirus - BioWorld
WEBSep 12, 2024 · The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note that we have added three critical tables, which are continuously updated: Vaccines and therapeutics in development. Diagnostics with U.S. FDA emergency use authorization.